Suppr超能文献

单核细胞与高密度脂蛋白比值可预测急性冠脉综合征患者的造影剂诱导的肾病。

Monocyte to High-Density Lipoprotein Ratio Predicts Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome.

作者信息

Ulus Taner, Isgandarov Kamal, Yilmaz Ahmet Serdar, Uysal Samet, Vasi Ibrahim, Dural Muhammet, Mutlu Fezan

机构信息

1 Department of Cardiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

2 Department of Internal Medicine, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

出版信息

Angiology. 2018 Nov;69(10):909-916. doi: 10.1177/0003319718760916. Epub 2018 Mar 4.

Abstract

Contrast-induced nephropathy (CIN) is associated with worse prognosis in patients with acute coronary syndrome (ACS). Early identification and intervention for patients with a high risk of CIN are very important to improve clinical outcomes. Inflammation plays important role in the development of CIN in the setting of ACS. The monocyte to high-density lipoprotein ratio (MHR) is a novel inflammatory marker. Bleeding is also associated with worse prognosis in such patients. We aimed to investigate whether the preprocedural MHR had a predictive role for CIN development in such patients. In addition, using the thrombolysis in myocardial infarction classification, we aimed to assess whether there was any relationship between bleeding and CIN. A total of 647 patients (496 males; age: 63.3 ± 12.7 years) with ACS who underwent percutaneous coronary intervention (PCI) were included in the study. Seventy patients (10.8%) had developed CIN. Age, diabetes mellitus, contrast volume, estimated glomerular filtration rate, and MHR were independent predictors for CIN. Preprocedural MHR may be used as a simple marker of CIN. It may help with the early identification of patients with ACS who underwent PCI who are at high risk of CIN thus allowing the planning of protective measures.

摘要

对比剂肾病(CIN)与急性冠状动脉综合征(ACS)患者的不良预后相关。对CIN高危患者进行早期识别和干预对于改善临床结局非常重要。炎症在ACS背景下CIN的发生发展中起重要作用。单核细胞与高密度脂蛋白比值(MHR)是一种新型炎症标志物。出血在这类患者中也与不良预后相关。我们旨在研究术前MHR对此类患者CIN发生是否具有预测作用。此外,使用心肌梗死溶栓分类,我们旨在评估出血与CIN之间是否存在任何关系。本研究纳入了647例接受经皮冠状动脉介入治疗(PCI)的ACS患者(496例男性;年龄:63.3±12.7岁)。70例患者(10.8%)发生了CIN。年龄、糖尿病、对比剂用量、估计肾小球滤过率和MHR是CIN的独立预测因素。术前MHR可作为CIN的一个简单标志物。它可能有助于早期识别接受PCI的ACS高危患者,从而有助于制定保护措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验